Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element

Cultivating connections and conversations for biopharma communicators

Welcome to Ticket to Biotech (T2B) – bringing together life science comms practitioners of all kinds and across all career stages to address our distinctive challenges. We share on-the-job insights and resources, learn from each other, and in turn, collectively improve our craft while paying it forward to the next generation.

Upcoming Programming

T2B Monthly

Sign up for our monthly email update to see what we're hearing from the community. T2B membership not required.

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.

Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element


Many comms practitioners are natural conveners. But we don’t always do a good job convening ourselves.That's where Ticket to Biotech (T2B) comes in. T2B is a communicator community with a mission to cultivate connections and conversations. Launched in October 2023 by Lynnea Olivarez, we seek to elevate our profession by bringing together experienced and emerging life science comms practitioners, alike, to address our distinctive challenges. We share on-the-job insights and resources, learn from each other, and in turn, collectively improve our craft while paying it forward to the next generation.T2B’s base 2024 programming is free and includes weekly community discussion topics in a private Slack workspace, press panels and media Q&As, monthly fireside chats with various subject-matter experts, AMA sessions, and peer-coaching groups. We also recently launched our first premium program from our Leadership Lab, the Corporate Advisor Series for senior communicators. We currently have 425 members and continue to expand in support of biopharma communicators globally.


I got hooked early.I've been a life science communicator for my whole career, supporting all stages of drug development and a variety of biopharma firms along the way.Although I've been incredibly privileged to build a durable support network, there've been so many other amazing comms pros in our niche field who I've wanted to meet and learn from. As I began to attain seniority, myself, more and more connections started asking me to share learnings, guidance and sometimes simple how-to's, too (for ex., what's with all the "potentially's"?).

T2B founder and community manager Lynnea Olivarez

Despite valuable experiences with the preeminent cell and gene therapy society and national PR association, it became abundantly clear that comms practitioners in our industry face unique challenges: Operating in a highly regulated environment while simultaneously striving to develop strategies that reflect the innovation biopharma is known for.To address this catch-22, I launched T2B, a dedicated space for our corner of comms. In addition to bringing fellow biopharma communicators together for a continuous, open dialogue, T2B provides a spectrum of networking and professional development offerings.I hope that joining our community will be as enriching for you as creating it has been for me. Thank you for coming aboard and being a part of this journey!

Getting Involved

Our goal is for T2B to be a space where you feel comfortable asking questions and imparting your own thoughts and perspectives, regardless of where or for whom you may work. Follow our community on LinkedIn, subscribe to our monthly emails, and if you’re a comms professional in our industry, join us. Whether you’re here to express your ideas or simply listen, we welcome you to T2B.

We're open to custom program and event sponsorships, including hosting future T2Bmeets. Contact us at tickettobiotech@gmail.com to talk!

Founding Advisory Board

Comprising communicators of all kinds, at all career stages, and from several global biopharma hubs, our ad board provides strategic guidance, feedback, and ideas to support T2B’s mission. This group plays a critical role in shaping our programming and growth strategies to ensure T2B's platform meets the evolving needs of our community.

Cynthia Clayton

Cynthia Clayton

Vice President,
Communications and Investor Relations
Third Rock Ventures

Cynthia joined Third Rock Ventures in 2015 as Vice President, Communications and Investor Relations. In this role, she leads the firm’s external and internal communications strategy and initiatives. She also works closely with the firm’s portfolio of companies to guide them on their communications and investor relations best practices. Prior to joining Third Rock, Cynthia served as Vice President, Investor Relations and Communications at Alnylam Pharmaceuticals for 10 years. Before that, Cynthia was Director, Investor Relations and Corporate Communications at Synta Pharmaceuticals. She joined Synta after four years in roles of increasing responsibility at Millennium Pharmaceuticals, where she worked as part of the team driving the company's communications and investor relations efforts. Cynthia began her career in Investor Relations and Corporate Communications at Curis. She earned her B.A. with honors in Communications from the University of Hartford in Connecticut.

Mikel Legette

Mikel Legette

Recent Graduate
Aspiring Biopharma Communicator

Mikel is a Caribbean American and a first-generation college graduate with a profound passion for healthcare and pharmaceutical marketing. He holds a double bachelor's degree in Psychology and Corporate Communication, Advertising, and Marketing from Baruch College, CUNY. Driven by a commitment to excellence, Mikel continually challenges change and innovation processes, takes initiative, amplifies voices, and achieves noteworthy outcomes through resourceful solutions. Mikel has interned at top Fortune 500 companies and pharma advertising agencies across the United States. Mikel started his career at JP Morgan Chase as a Data Analyst. He then transitioned to healthcare marketing, interning at Publicis Health Saatchi & Saatchi Wellness and later as Global Communications Intern at Merck & Co. Inc.Mikel's interests extend beyond his professional pursuits. He has a deep passion for the culinary arts and a meticulous eye for digital design. His love for travel adventures, exploring different cultures, and listening to music not only enrich his life but also contribute to his creativity and analytical thinking, setting him apart as a young individual.

Lina Li

Lina Li

Senior Director, Investor Relations and Corporate Communications
Intellia Therapeutics

Lina is a senior director of investor relations and corporate communications at Intellia. Since joining Intellia in 2017, Lina has played a pivotal role in shaping the company’s public and investor-facing communications through various stages of clinical development for its gene editing therapies. She was responsible for leading the communication strategy for the landmark data presented in 2021, supporting the use of CRISPR/Cas9 to specifically edit genes inside a human body. She has deep experience translating complex science associated with novel gene editing technologies and across multiple therapeutic areas for the investor and media audience. In her role, she has successfully supported over $1B+ of capital market financings to drive Intellia’s research and development forward. Prior to Intellia, Lina held roles of increasing responsibility in finance and accounting at KKR and PwC. She graduated with a dual B.S./M.S. degree in Accounting from the New York University Stern School of Business and is a Certified Public Accountant.

Ilke Limoncu

Ilke Limoncu

Lead, Communications and Public Affairs, Business Unit Oncology

Ilke is a seasoned, strategic healthcare communications executive who achieves top-tier results to build, maintain and protect reputations for Fortune 50 biopharma companies. A 20-year veteran of Abbott and AbbVie, she currently leads integrated communications for AbbVie’s oncology portfolio. Her experience extends across all facets of proactive and issues management external (media, consumer, social) and internal (executive, employee) communications, and she has launched multiple pharmaceutical brands, indications and high-profile campaigns. Prior to Abbott and AbbVie, she held positions of increasing responsibility at Baxter Healthcare, Weber Shandwick, Golin and GCI Health. Ilke’s and her teams’ work has been widely recognized, including through the Public Relations Society of America (PRSA) Silver Anvil and Ragan Communications and Reuters Pharma awards for best campaigns in Corporate, HIV/AIDs, Cardiovascular Health and Oncology communications. Ilke is a member of the Daughters of Ataturk International, PRSA and Ragan Communications, and she is a founding member of the Ticket to Biotech advisory board, promoting excellence in healthcare-industry communications. She holds a Journalism degree from Indiana University in Bloomington, Indiana.

Sarah MacDonald

Sarah MacDonald

Life Science Cares

Sarah joined Life Science Cares as Employee #1 in 2017 and has overseen the organization’s explosive growth and strategic direction since. As CEO, she drives the alignment, efficiency and effectiveness of LSC’s five affiliates. Under her leadership, Life Science Cares has invested more than $16 million and tens of thousands of volunteer hours to support a portfolio of community organizations providing access to basic needs, access to education and access to opportunity.Before joining LSC, Sarah served as Executive Vice President at MassBio, the industry trade association. In that role, Sarah led policy, communications, events and strategic functions of the 1,000+ member company organization. Prior to MassBio, Sarah held a variety of association and policy positions. She is a graduate of Hartwick College and has a Master’s degree from Northeastern University.Outside of work, Sarah is active in her community and enjoys time with her husband, Sean and son, Griffin.

Trista Morrison

Trista Morrison

Chief Corporate Affairs Officer and Chief of Staff to the CEO
Voyager Therapeutics

Trista is a seasoned biopharmaceutical executive advisor and cross-functional strategist, with 20+ years of experience in corporate affairs and stakeholder management (investors, media, employees, patients) for public companies. Trista currently serves as the Chief Corporate Affairs Officer and Chief of Staff to the CEO at Voyager Therapeutics (NASDAQ: VYGR). She also serves on the Board of Directors for the Network of Tyrosinemia Advocates (NOTA) and the Advisory Board of The Termeer Foundation. Prior to joining Voyager, Trista served as Chief Corporate Affairs Officer for Saniona, where she built and led communications, investor relations, patient advocacy and government relations, in addition to serving as a member of the executive committee. She previously founded the consulting firm PR with Purpose, and her prior roles include Vice President of Communications and Patient Advocacy for rare disease company Sobi in North America, Head of Communications for Ironwood Pharmaceuticals, and reporter and editor for BioWorld Today, as well as various positions at multiple communications agencies. Trista received a B.S. in marketing and biology from Tulane University.

Sherry Pudloski

Sherry Pudloski

Group President of Client Solutions, Integrated Communications
Real Chemistry

Sherry is a strategic advisor at Real Chemistry with experience and expertise across the entire healthcare ecosystem in product and corporate communications, healthcare policy, public affairs, investor relations and sustainability. Most recently, Sherry was Chief Corporate Affairs Officer at Seagen, where she was instrumental in supporting the company’s $43 billion acquisition by Pfizer. Previously, she served in various communications, strategy and corporate affairs leadership roles at Pfizer, Novartis, Zoetis and Guardian Life and led Ogilvy PR’s global health practice. At Pfizer, she was the Founder of the N.Y. Women's Council and served as the U.S. Chair for its Global Women's Council. Sherry currently serves on the Board of Advisors for Jhpiego Corporation, a Johns Hopkins affiliated international health organization providing services for women and families in more than 155 countries and is vice chair of the Board of Trustees at Maryvale Preparatory School. She lectures in communications at New York University and Georgetown University.

Priyanka Shah

Priyanka Shah

Founder & CEO
Elephant Head Communications LLC

Priyanka is the Founder and Chief Executive Officer of Elephant Head Communications, LLC, a strategic communications consultancy dedicated to helping companies in the life sciences, biopharma, and biotech sectors effectively convey their innovations and purpose. With over 18 years of experience, Priyanka is known for her strong work ethic, rooted in hard work, grit, empathy, and humility, offering an influential perspective for leaders navigating business challenges. In her previous leadership roles at Kinnate Biopharma and Mirati Therapeutics, she played a pivotal role in shaping their external affairs strategies during crucial transitions. At Bristol Myers Squibb, she led corporate communications through significant milestones, including the acquisitions of Celgene and Myokardia and managed global oncology communications for flagship products like Opdivo and Yervoy. Priyanka has been recognized as a leader of influence by the San Diego Business Journal and PRWeek. She also dedicates her time to community service, supporting organizations like Penn Medicine and Mama’s Kitchen. Priyanka holds a B.A. and an M.A. in Communications from Rutgers University.

Scott White

Scott White

Executive Vice President & Principal Recruiter

Scott is an EVP and Principal Recruiter at HireMinds. He has over two decades of professional executive recruiting experience. Scott specializes in placing communications, marketing, investor relations, and patient advocacy professionals in many industries. Most of his work is in the pharma, biotech, and medical device sectors. He works with clients and candidates across the country.Scott is a frequent lecturer at universities and professional associations, where he shares tips on how to write cover letters, resumes and LinkedIn profiles, how to leverage your network and how to prepare for interviews. When he’s not recruiting, he loves to travel, work on home projects and play catch with his Goldendoodle, George.

Matt Worrall

Matt Worrall

Director of Corporate Communications & Public Affairs
Ferring Pharmaceuticals

Matt has been in working in healthcare and life science communication for more than 20 years for a wide range of organisations including charities, trade associations and medical societies before switching to work for pharma and biotech for AbbVie, Merck & co (MSD) and now Ferring. Matt is passionate about the important role industry must play in supporting health literacy and accessible information for all. He works to develop the strategic impact pharma communicators can have through stakeholder engagement, story telling, policy development and adoption of media technology.

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.

Bios now live on about page

Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element


  • Public / media relations and external communications

  • Corporate and/or public affairs

  • Integrated communications

  • Marketing communications

  • Internal communications

  • Strategic communications

  • Visual storytellers and graphic designers

  • Aspiring biopharma communicators

The following are ineligible for T2B Slack community participation, but are welcome to follow us on LinkedIn:

  • In-house recruiters / TA and recruitment agencies

  • Reporters / bloggers

  • Service providers outside PR agencies and consultants

  • Anyone else trying to directly sell something or get leads


Ticket to Biotech Slack workspace channels provide a variety of ways to participate. Join one or join them all!

Ticket to Biotech Slack announcements channel icon


We curate snapshots, which we also post to LinkedIn. Topics include: recent #hot-topics takeaways, new #resources, and new job openings for #talent.

Ticket to Biotech Slack hot topics channel icon


We seed ≥one topic per week. Ex: corporate social activism areas, hybrid working strategies, AI(!), cool internal tools having a moment… and more.

Ticket to Biotech Slack water cooler channel icon


Post those questions that you think are silly but that everyone is actually thinking about. Tell us what’s on your mind.

Ticket to Biotech Slack resources channel icon


Our knowledge center. We post reports, Substack and LI posts that caught our eye, and home-grown content over time.

Ticket to Biotech Slack talent channel icon


Share any biopharma comms job openings you have on your team or that you’ve seen somewhere on a public channel.


A highly sought-after feature by the T2B community is the chance to connect with biopharma comms peers locally.The T2B Slack workspace offers dedicated networking channels for the three leading U.S. life science hubs:

  • San Francisco Bay Area

  • Greater Boston Area

  • San Diego (SoCal)

Ticket to Biotech regional networking groups in the San Francisco Bay Area, Greater Boston and SoCal

As the T2B community expands, we'll introduce more regional networking channels.

T2B Resources

Special resources designed just for biopharma communicators! Join T2B for access to the Biopharma PR & Comms Firms Directory and more insider insights.>> NEW! Fierce Pharma PR East AI Resources
>> Biopharma Communicator Career Ladder
>> Professional Groups & Societies
>> 2024 Awareness Days & Holidays

2024 Programming

This year's offerings are based on T2B community feedback, numerous conversations and our own past experience. We hope that at least one of these catches your eye and that you’ll stick around to engage as part of our burgeoning communicator community. Click below + follow us on LI and in Slack for details. All base programming is free and open to T2B community members. Request to join T2B here to engage and attend. Sign up for our T2B Monthly email updates here (T2B membership not required).💬 Weekly Community Discussion Topics
Timely topic tied to what’s happening in the news, an emerging industry trend, or an upcoming T2B event or resource release. We started these last year, and members have asked us to keep the discussion going! How it works:
- We seed a discussion topic ~each week in Slack with a corresponding LinkedIn post (with a video!) sharing the situation, our take and community questions
- One-question anonymous poll in Slack for quick engagement
- Roundup of key takeaways from discussion posted to Slack and LinkedIn
🔥 Monthly Comm Convos
SME 1:1 fireside chat or moderated panel highlighting biopharma comms interest areas. How it works:
- Vetted expert shares perspective and practical tips, followed by open Q&A
- Speakers will be a combination of folks from industry and people we love and admire beyond biopharma, to bring the outside in
- Log into Slack for recordings of February's Comm Convo, “Op-Ed Edge With Jake Meth"; March's Comm Convo, "Patient-Focused Comms With Jen Helfer"; April's Comm Convo, “Service-Driven Success With Sarah MacDonald, of Life Science Cares”; May's Comm Convo, "Navigating the Biopharma Comms Hiring Landscape With Alma Villaseñor Hembree;" June's Comm Convo, "Embracing Diversity & Allyship in Biopharma Comms With Lex Clay;" and "Practical AI Applications for Corporate Affairs With Daniel Mendez."
- Registration now open for our August Comm Convo, "(Social) Influencing for the Future With Annie-Mai Hodge." More info and RSVP here.
🎙️ AMA Series
Reddit-style Ask Me Anything series on our private T2B Slack workspace with various thought leaders. How it works:
- We've had AMAs with a recruiter and DEI strategist so far.
- Our next AMA is focused on how AI is impacting comms and our industry more broadly. Our guest is Shirley Mao, who's launched dozens of AI products, including in the healthcare and life sciences space. Sign up here.
- After registering and confirmation of your T2B community membership, we'll add you to our new #ama channel in Slack.
🌐 Annual Peer-Learning Practicum
Peer-coaching group model enables communicators with diverse focus areas and experience levels to find unique value from each other and network on a deeper level. How it works:
- Virtual program opens participation opp to communicators globally and at all levels
- Ties into monthly Comm Convo focus area for a seamless experience
- 2024 PLP registration closed
💼 Leadership Lab
As T2B's first premium program, the Corporate Advisor Series is designed to elevate the influence of communications leaders in highly regulated environments like ours, aligning directly with both our functional and corporate objectives.
- Fall six-week virtual workshop for senior biopharma communicators
- Exclusive networking opportunity
- Private 1:1 executive coaching session
- Program details and early bird pricing here
- T2B's second Leadership Lab program with executive coach Carly Goldsmith is called "Master Your Message" and is a one-hour virtual workshop on July 31st, free and open to communicators at all career stages. More info and RSVP here
Monthly Pulse Narratives
Series shines a light on the diverse and dynamic professionals in the T2B community, facilitating new connections. How it works:
- Participants select favorite topics from robust question bank
- Each Narrative covers background, deep dive on biopharma comms expertise, experience with T2B, and a fun fact, motto or quote; first edition here
- Nominations (self-nominations OK, too!) now open
📰 Monthly Biopharma Beats Bulletins
Helping beat reporters help T2B members -- spotlight resulting in short, action-oriented guide for T2B members. How it works:
- Requested by T2B members as a high value-add resource
- Bulletin posted to Slack covers the profiled journalist’s background, beat overview, what they’re watching, pitching tips, pet peeves, events/conferences they plan to attend, and a key quote
- Profiled journalists include GEN's Alex Phillipidis, C&EN's Rowan Walrath, BioSpace's Jef Akst, DD&D's Brian Buntz, DDN's Stephanie DeMarco, and IBD's Allison Gatlin (full guides in T2B Slack)
🎤 ~Quarterly Press Pass Panels
Following successful Pre-JPM Press Pass panel, we’re bringing this back, by popular demand! Moderated panels where reporters share their candid take and best practices. How it works:
- Bring together several top reporters for interactive virtual session
- RSVP here for our next virtual event, "Press Pass to the Newsroom: Endpoints Edition" on August 21st
🤝 T2Bmeets
Free industry event companion meet-ups.
- Lots of fantastic energy at our most recent T2Bmeets @ JPM ‘24 and BIO '24, and at our regional SF Bay Area meetup @ AbbVie!
- Join us in Boston on July 11th for our first IRL networking event in Beantown, sponsored by our friends at MassBio, The Castle Group, and AbbVie!
💡 Topic-Specific Roundtables
Roundtables provide specialized expertise and strategic input on topic-specific programming and professional development for the community.
- Each roundtable, comprising a chair and five members, actively contributes to the conceptualization, production, and hosting of T2B’s offerings related to a specific focus.
- Launched in July 2024, the first is the Media Minds Roundtable, chaired by Becky Vonsiatsky, of Real Chemistry. This is a pilot initiative, with the intent to introduce more groups in 2025.
📇 T2B Member Directory
New resource coming soon capturing T2B members’ existing contact info and background. Directory will maximize community connections for networking, learning, and job searching.

Press Pass to JPM highlights reel... Stay tuned for 2024 panels


T2B Slack guideline #1

Chatham House Rule – sort-of.

We totally get that Slack = putting things in writing, but we ask all community members to go by the honor code: OK to cite (but not attribute) examples and ideas in your internal company discussions. No screenshots or mentions on external channels without prior permission from the community contributor.

T2B Slack guideline #1

No solicitations or ads for services.

Period. This includes no “open to work” or resume posting. If you see a job you want to apply for in the #talent channel, contact the person who posted it directly.


After we verify your participation eligibility, you’ll receive a confirmation email with a direct link to the T2B workspace. You'll also be eligible to register for upcoming T2B programming.If you haven’t used Slack before, visit Slack.com to create a free account. You can easily access Slack in several ways:

Remember to follow us on LinkedIn

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.

Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element


1. IntroductionWelcome to Ticket to Biotech (T2B). We respect your privacy and are committed to protecting your personal data. This privacy policy will inform you about how we look after your personal data when you apply to join our community and tell you about your privacy rights and how the law protects you.---2. Important Information and Who We ArePurpose of this Privacy PolicyThis privacy policy aims to give you information on how T2B collects and processes your personal data when you apply to join our community.ControllerTicket to Biotech is the controller and responsible for your personal data.---3. The Data We Collect About YouWe may collect, use, store, and transfer different kinds of personal data about you which you have provided to us including:- LinkedIn profile link for validation purposes.
- Email for T2B community updates.
- T2B Slack workspace messages in public channels.
---4. How We Use Your Personal DataWe will only use your personal data for the purpose for which we collected it which include the following:- To validate your eligibility to join the T2B community.
- To send you an automated email from "Slack" inviting you to the T2B Slack workspace.
- To send you a separate welcome email from T2B.
- To provide T2B community updates from time to time.
---5. Disclosures of Your Personal DataBy signing up to the Ticket to Biotech community, participants acknowledge that we may, in the future, share their email addresses with T2B partners for collaborative and promotional purposes. Apart from this, we may share your personal data with third parties where required by law, where it is necessary to administer the working relationship with you, or where we have another legitimate interest in doing so.---6. Data SecurityWe have put in place appropriate security measures to prevent your personal data from being accidentally lost, used, or accessed in an unauthorized way, altered, or disclosed. In addition, we limit access to your personal data to those employees, agents, contractors, and other third parties who have a business need to know.---7. Data RetentionWe will only retain your personal data for as long as necessary to fulfill the purposes we collected it for, including for the purposes of satisfying any legal, accounting, or reporting requirements.---8. Your Legal RightsUnder certain circumstances, you have rights under data protection laws in relation to your personal data. These include the right to:- Request access to your personal data.
- Request correction of your personal data.
- Request erasure of your personal data.
- Object to the processing of your personal data.
- Request restriction of processing your personal data.
- Request transfer of your personal data.
- Right to withdraw consent.
---9. Changes to the Privacy Policy and Your Duty to Inform Us of ChangesWe keep our privacy policy under regular review. This version was last updated on September 1, 2023. It is important that the personal data we hold about you is accurate and current. Please keep us informed if your personal data changes during your relationship with us.---10. Contact DetailsIf you have any questions about this privacy policy or our privacy practices, please contact:Community curator: Lynnea Olivarez
Email: tickettobiotech@gmail.com
---By applying to join the Ticket to Biotech community, you acknowledge that you have read and understood this Privacy Policy.

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.

Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element

Press Pass to JPM: A Pre-Conference Conversation with Top Reporters

T2B's inaugural event is designed specifically for biopharma communicators! As we gear up for the JP Morgan Healthcare Conference (JPM) in January, it's time to delve deeper into the journalistic perspectives that shape our industry's narratives.📅 Date: Tuesday, November 28th
🕐 Time: 1-2 p.m. ET
📍 Location: Virtual
Open to all T2B community members, this is a panel with life science journalists and JPM veterans, Allison DeAngelis (STAT), Emily Mullin (Wired), and Gwendolyn Wu (BioPharma Dive). We'll explore their intended focus areas at JPM '24, the trends that will pique their interest for next year, and the sources and expertise they're looking for. We've scheduled this event to aid the T2B communicator community in forging meaningful connections with reporters right when outreach for JPM interactions begins.


  • Gain exclusive insights into the journalistic focal points for the upcoming JPM.

  • Understand the trends and topics that will dominate life science reporting in 2024.

  • Discover the companies and expertise journalists are eager to engage with.

  • Strategize your outreach effectively by knowing who to target for JPM meetings.


Allison DeAngelis, STAT

Allison DeAngelis is a biotech reporter at STAT, covering biopharma startups and venture capital. Prior to joining STAT, Allison covered the drug industry at Insider and the Boston Business Journal. She was named the Washington Newspaper Publishers Association's News Writer of the Year in 2016. She is based in Boston.

Allison DeAngelis, STAT

Emily Mullin is a staff writer at WIRED, covering biotechnology. Previously, she was an MIT Knight Science Journalism project fellow and a staff writer covering biotechnology at Medium's OneZero. Before that, she served as an associate editor at MIT Technology Review, where she wrote about biomedicine. Her stories have also appeared in National Geographic, Scientific American, Smithsonian Magazine and The Washington Post, among other outlets. She has a master's degree in science writing from Johns Hopkins University.

Allison DeAngelis, STAT

Gwendolyn Wu is a reporter at BioPharma Dive covering biotech startups, venture capital and the ecosystem that supports them. Previously, she authored Bay Briefing, the San Francisco Chronicle’s flagship weekday newsletter, and covered COVID-19 and the business of healthcare for the Houston Chronicle. Outside of the newsroom, Gwendolyn co-directs the AAJA Young Professionals Network, and teaches at the California Scholastic Press Association summer workshop. She has degrees in history and sociology from the University of California at Santa Barbara.


Thank you for your interest in T2B! Join our community by requesting an invite via the link below. Gain access to a recording of this event and be the first to know about future programming.

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.

Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element

Comm Convo

Join us to kick off T2B's 2024 Comm Convo series, where we'll have candid, monthly 1:1 conversations with top-notch comms experts. During each fireside chat, we'll pull back the curtain on a specific topic to inform your own life sci comms strategies. We'll also devote a section of every Comm Convo for open audience Q&A.

Op-Ed Edge: Crafting Compelling Narratives with Jake Meth

February's Comm Convo features Jake Meth, founder of op-ed consultancy Opinioned and former editor of commentary at Fortune magazine. He'll share his insights on spotting opportunities for impactful op-eds and bylined articles, emphasizing the importance of a unique point of view in the crowded biopharma landscape. Get his take on how to craft narratives that not only inform but also influence, and learn practical strategies for pitching them to top-tier editors effectively.📅 Date: Tuesday, February 6th
🕐 Time: 1-2 p.m. ET
📍 Location: Virtual
For more on Jake’s approach to op-ed success, check out his free "Pitches Get Stitches" newsletter.


  • Gain first-hand knowledge from Jake, leveraging his experience as a top-tier editor to elevate your op-ed strategy.

  • Learn how to identify and articulate perspectives that make your op-eds stand out in the biopharma sector.

  • Understand how to integrate op-eds into a broader thought leadership program, enhancing your brand’s influence.

  • Hear Jake's tips for pitching and landing your pieces with leading publications, beyond the typical trade press.


Jake Meth, Opinioned

Jake Meth started Opinioned because he wanted to see more original ideas in the media after spending five years building and editing Fortune magazine’s commentary section.Drawing on his editorial leadership experience, Jake founded Opinioned and now guides various industry leaders -- and communicators like us at T2B -- in shaping thought leadership programs with narratives that resonate on a global stage.Jake started in journalism after graduating from college, when he moved to Egypt for two years to cover the Arab Spring uprising for a local newspaper. Following that, he relocated to New York and worked in media relations for Foreign Affairs magazine and the Council on Foreign Relations.Jake received the 2020 New York Press Club award for excellence in journalism in the magazine consumer reporting category for his Fortune investigation into the epidemic of laundry pod poisonings among young children.He lives in Jersey City, NJ., and enjoys doing improv, eating good food and being a plant dad.

Registration Closed

Thank you for your interest in T2B! Join our community by requesting an invite via the link below. Gain access to a recording of this event and be the first to know about future programming.

Interested in sponsoring?

Comprehensive sponsorship tracks are in the works, but in the interim, we’re making available a one-time only opp to sponsor our February programming a la carte. There are limited sponsorships available for this February Comm Convo and other offerings. Help us keep programming free this year!

Special Thanks to our sponsor

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.

Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element
Leadership Lab Logo

This six-week virtual workshop is designed for senior biopharma communicators (≥15 years of experience) who seek to elevate their influence as corporate advisors and leaders in a complex and highly regulated environment. As the first offering in Ticket to Biotech’s Leadership Lab program, the Corporate Advisor Series will highlight the comms function’s evolution toward a strategic corporate affairs role by exploring leadership in three parts: leading the business, leading yourself, and leading others.Executive coach Carly Goldsmith will facilitate a blend of interactive executive development and practical application sessions that empower senior professionals from agency, consultancy, and in-house backgrounds to challenge conventional preconceptions, augment your critical business advisory skills, and enhance your effectiveness in decision-making roles.You’ll also meet individually with Carly for a one-hour coaching session to address any specific challenges, further improve personal leadership skills, and directly apply learnings from the workshop.

What to Expect: ROI

Exclusive Networking: Connect with other veteran biopharma communicators facing similar challenges, sharing learnings and best practices.Executive Professional Development: Capitalize on small-group leadership coaching to hone competencies tailored to the unique demands of our highly specialized profession.Enhanced Leadership Influence: Gain skills to position the comms function – whether you’re an individual contributor or lead a large team – as a key decision-making partner.

Meet Carly at Our Complimentary "Master Your Message" Workshop

Deciding whether now is the right time to invest in tailored executive coaching? Experience T2B's second Leadership Lab program, and get a sense for Carly's style while you're at it:Ironically, we comms folks are not always great about promoting ourselves, even though we do it for others for a living!In this one-hour virtual workshop, Carly will equip you with a refreshed strategy for refining your personal messaging. Whether it’s articulating your leadership philosophy, your career achievements, or your vision for the future, this workshop will provide the tools to craft –or update– your narrative with clarity and confidence.🗓️ Wednesday, July 31st @ 12-1 p.m. ET / 9-10 a.m. PT
📍 Virtual
Free and open to communicators at all career levels.

Program Details

All participants will receive a T2B Leadership Lab certificate upon completion of the Corporate Advisor Series.Module 1: Leading the Business
Whether you have seat at the table or are trying to get one, the ability to express a point of view and influence the direction of the business is critical. Carly will equip the group with new ways to advocate for the role Comms/Corporate Affairs can play in the success of the business. We’ll take a fresh look at opportunities to effectively advise leaders on what to do and where to invest to drive business goals and decisions, as well as how to educate key stakeholders — whether internal business partners or clients — on the most effective means of collaborating with our function. Our practical applications lab in week 2 will provide a supportive space for participants to share insights, experiences, and strategies for growth with one another.
• Week 1: Interactive Executive Coaching Session
Tuesday, 9/3 @ 12:30-1:30 p.m. ET
• Week 2: Practical Application Lab
Tuesday, 9/10 @ 12:30-1:30 p.m. ET
Module 2: Self-Leading
Evolving Comms roles means that more and more will be demanded of us. A rapidly changing, complex and ambiguous world requires communicators to increase self-awareness and self-management. By fostering self-trust and embracing vulnerability, we can cultivate positive and sustainable practices and embrace a growth mindset. Reflecting on the beliefs and doubts that might be holding us back, we’ll learn strategies for increasing the self-management and confidence required to meet these demands. In week 4, Carly will guide a practical applications lab where participants can discuss both learnings and fears, from managing stress to imposter syndrome.
• Week 3: Interactive Executive Coaching Session
Tuesday, 9/17 @ 12:30-1:30 p.m. ET
• Week 4: Practical Application Lab
Tuesday, 10/1 @ 12:30-1:30 p.m. ET
Module 3: Leading Others
Whether leading a department of one or of many, biopharma communicators are building relationships down, up, across, and sometimes outside of the organization. Alignment with key stakeholders on our business function’s goals and objectives, strategy, and scope undoubtedly will become even more integral to our success with the evolution of our role. Carly will coach us on approaches to effectively provide feedback to colleagues, collaborate with others across the organization or client base, and develop staff to meet the expanded demands of both the business and the role in this changing environment. Our final practical applications lab will offer a space to reflect on the considerations and challenges of managing expectations, relationships, and teams.
• Week 5: Interactive Executive Coaching Session
Tuesday, 10/8 @ 12:30-1:30 p.m. ET
• Week 6: Practical Application Lab
Tuesday, 10/15 @ 12:30-1:30 p.m. ET
1:1 One-Hour Individual Executive Coaching Session
In this customized 1:1 coaching session with Carly, you’ll have an opportunity to address any specific challenges you’re having, enhance your personal leadership skills, and directly apply learnings from the workshops. You’ll be able to schedule this session at your convenience in September or October. Details to be provided following program acceptance.

About Our Facilitator

Carly Goldsmith

Carly Goldsmith is a Professional Certified Coach (PCC) with over 20 years of experience coaching high-potential senior and emerging leaders and their teams. She is a versatile and trusted partner who supports leaders to create real impact and sustainable results through improvements in their effectiveness, cohesion, and performance. Compassionate and intuitive by nature, Carly’s style is often described as engaging, insightful, and empowering.Carly has coached leaders across multiple industries throughout the US and globally. In addition to her coaching, she has designed and facilitated in-person and virtual workshops, leadership development programs and team coaching engagements. Recent clients include Deloitte, Amazon, Charles River Associates, Verve, ImmunoGen/AbbVie, Teradata, Alnylam, Dragonfly, Broad Institute, Mass General Brigham, Dana Farber, Alexion, Morgan Stanley, SCAN Foundation, and Needham Bank.

• Professional Certified Coach (PCC)
• The LVI 360 (Kaiser Leadership)
• The Hogan Suite
• Embodied Transformation (Strozzi Institute)
• Benson-Henry Stress Management & Resiliency Training program
• Fearless Organization Scan (Psychological Safety)

• Smart Collaboration Accelerator
• Team Coaching Core Program (Corentus)
• Team Diagnostics (Team Coaching International)
• Voices 360 (Korn Ferry)
• EQ-I 2.0 (MHS)

Workshop Participant qualifications

The Corporate Advisor Series Fall 2024 cohort is limited to 15 senior biopharma communicators. Program acceptance subject to T2B organizer discretion.• T2B member (confirm your eligibility, and complete our two-minute intake form if you’re not already part of our community)
• ≥15 years of experience as an advanced senior- or executive-level communicator (see Biopharma Communicator Career Ladder)
• Commitment to reflect, learn, and engage, including completing pre-workshop survey and periodic homework assignments


STEP 1: Complete this application form.Your application will not be reviewed until full payment is received (see Step 2 below). Each submission will be evaluated on a case-by-case basis, with full refunds issued for any unapproved applications. Under no other circumstances will we issue refunds.

STEP 2: Select the appropriate payment option (honor system), and remember to use a promo code if you have one!Take advantage of a 15% discount with early bird pricing available through July 12, 2024. Starting July 13th, the self-pay price will increase to $4,295, and the company-pay price will increase to $4,995.

Frequently asked questions

What kind of communicators can participate in this program?
If you’re already a T2B member and have at least 15 years of biopharma comms experience, you’re already eligible to join. If you’re new to T2B, confirm your eligibility here and request to join here before registering for this program. Note that our fall 2024 cohort is limited to 15 senior biopharma communicators, and program acceptance subject to T2B organizer discretion.
Why is the pricing different if my company pays for me to attend?
The higher company-pay rate reflects the direct benefits to organizations in terms of enhanced strategic capabilities and leadership skills their employees will gain through this Corporate Advisor Series. The self-pay rate is slightly lower, making it accessible for individuals investing in their own development.
Do you offer refunds?
Each submission will be evaluated on a case-by-case basis, with full refunds issued only for any unapproved applications. Under no other circumstances will we issue refunds. Otherwise, the program fee is nonrefundable. In certain circumstances, we may be able to switch your registration with an alternate program candidate on the waitlist, though this is not a guarantee. Contact us at tickettobiotech@gmail.com for details.
Is there a waitlist?
Contact us at tickettobiotech@gmail.com and we’ll add you to the waitlist on a first-come, first-served basis.
What if I can’t join all six sessions?
We understand that things come up – no problem. We encourage you to catch up on key takeaways via our email recaps. (There will be no makeup sessions.) You'll have the opportunity to schedule your 1:1 one-hour executive coaching session with Carly at your convenience in September or October.
Will workshop sessions be recorded?
To preserve confidentiality, the sessions will not be recorded, but we'll provide session recaps to the cohort.

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.

Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element
Media Relations Roundtable Logo

The T2B Media Minds Roundtable provides specialized expertise and strategic input in this critical pillar of programming and professional development for the community. Roundtable member volunteers will actively contribute to the conceptualization, production, and hosting of T2B’s media-related offerings.We seek to enhance our awareness of reporters’ distinctive and evolving needs by directly improving working relationships with journalists who cover our industry. Ultimately, the goal of all T2B media relations programming is to create a more cohesive and efficient communicator ecosystem across the life sciences to shape the future of storytelling in healthcare.This roundtable launch is a pilot initiative aimed to enhance T2B’s offerings in media relations by leveraging the unique insights and connections of its members. If successful, we’ll roll out additional topic-specific roundtables in 2025.

Roundtable Objectives

• Conceptualize and develop quarterly press panel ideas and create outreach lists.
• Identify targets for monthly Biopharma Beats Bulletins (media Q&As), with opportunity to provide input on questions and potentially sit in on the interviews.
• Develop media invite lists for specific T2Bmeets.
• As needed, leverage professional connections to engage reporters in T2B events and programming.
• Suggest updates and/or new programming ideas focused on media relations.

Why Join

• Enhance your professional visibility and impact among the T2B community of 425 communicators.
• Build on your media relationships and establish new connections by leveraging T2B's brand and mission (vs. pitching for your company or client).
• Help set the standard for biopharma media relations best practices and strategies.

About the Chair

Carly Goldsmith

As Practice Leader of Earned Media at Real Chemistry, Becky Vonsiatsky is a versatile communications strategist known for her leadership to build and scale high-performing teams, deliver award-winning communications and marketing results spanning the healthcare ecosystem, and her ability to creatively address operational challenges with solutions that are widely adopted.Her future-forward approach to storytelling helps healthcare companies reach their stakeholders and drive measurable business outcomes. Working on the frontlines with leading pharmaceutical, medtech and biotech clients, her strategy is rooted in a deep understanding of today’s complex health environment, the evolving media landscape, and tomorrow’s consumption habits.Becky serves as an advisory council member for Harvard Business Review and has been recognized for her accomplishments as one of Medical Marketing and Media's (MM+M) 2023 40 Under 40.

Roundtable Member Role Scope

Term: This pilot will run during 2H2024 (July-December). If determined to be successful, the chair and members will have the opportunity to continue in their roles for the following calendar year, through YE 2025.Time Commitment: Estimated 3-5 hours/monthResponsibilities:
• Actively participate in quarterly meetings and contribute ideas and feedback.
• Assist in conceptualizing press panel topics and developing target lists.
• Help identify and reach out to potential editors and reporters for T2B events.

Roundtable Member Eligibility

The Media Roundtable is limited to five members. Program acceptance subject to T2B organizer and Roundtable Chair discretion.• Must be a T2B member (confirm your eligibility, and complete our two-minute intake form if you’re not already part of our community)
• Experience in life sciences media relations is preferable.
• Open to communicators with a passion for and commitment to developing their media relations skills and reporter relationships.


Register your interest in joining the Media Minds Roundtable by completing this application.Deadline: EOD PT Monday, July 22nd. We'll notify accepted candidates later that week.Questions? Contact us at tickettobiotech@gmail.com.

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.

Ticket to Biotech logo
Ticket to Biotech biopharma community gradient graphic element
T2Bmeet @BIO

This come-and-go continental breakfast is free and open to all T2B community members. Whether you're based in SoCal or visiting for BIO, we hope to see you there.📅 Date: Tuesday, June 4th
🕐 Time: 7-10 a.m. PT
📍 Location: 2031 Commercial St, San Diego, CA 92113
BIO International Convention registration not needed, but advance breakfast signup is required. If you're new to T2B, first confirm that you're eligible and fill out this form to join our community.

Silver Sponsor

Waterhouse Brands

Click here for more info on sponsoring T2Bmeet @ BIO.

Ticket to Biotech biopharma community gradient graphic element

© 2024 Ticket to Biotech. All rights reserved.